SQZ Biotechnologies Statistics Share Statistics SQZ Biotechnologies has 29.49M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 29.49M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 21.49M Failed to Deliver (FTD) Shares 22,357 FTD / Avg. Volume 4.04%
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios The PE ratio is -0.27 and the forward
PE ratio is null.
SQZ Biotechnologies's PEG ratio is
-0.03.
PE Ratio -0.27 Forward PE n/a PS Ratio 1.01 Forward PS n/a PB Ratio 0.37 P/FCF Ratio -0.25 PEG Ratio -0.03
Financial Ratio History Enterprise Valuation SQZ Biotechnologies has an Enterprise Value (EV) of -14.92M.
EV / Sales -0.71 EV / EBITDA 0.25 EV / EBIT 0.18 EV / FCF 0.18
Financial Position The company has a current ratio of 3.12,
with a Debt / Equity ratio of 0.48.
Current Ratio 3.12 Quick Ratio 3.14 Debt / Equity 0.48 Debt / EBITDA -0.46 Debt / FCF -0.33 Interest Coverage -8.3
Financial Efficiency Return on Equity is -136.91% and Return on Invested Capital is -93.89%.
Return on Equity -136.91% Return on Assets -78.32% Return on Invested Capital -93.89% Revenue Per Employee $396.77K Profits Per Employee $-1.48M Employee Count 53 Asset Turnover 0.21 Inventory Turnover n/a
Taxes Income Tax -1.22M Effective Tax Rate 1.54%
Stock Price Statistics The stock price has increased by 745.96% in the
last 52 weeks. The beta is 2.71, so SQZ Biotechnologies's
price volatility has been higher than the market average.
Beta 2.71 52-Week Price Change 745.96% 50-Day Moving Average 0.15 200-Day Moving Average 0.68 Relative Strength Index (RSI) 30.63 Average Volume (20 Days) 553,611
Income Statement In the last 12 months, SQZ Biotechnologies had revenue of 21.03M
and earned -78.24M
in profits. Earnings per share was -2.72.
Revenue 21.03M Gross Profit 21.03M Operating Income -80.68M Net Income -78.24M EBITDA -59.28M EBIT -69.75M Earnings Per Share (EPS) -2.72
Full Income Statement Balance Sheet The company has 63.71M in cash and 27.47M in
debt, giving a net cash position of 36.24M.
Cash & Cash Equivalents 63.71M Total Debt 27.47M Net Cash 36.24M Retained Earnings -274.97M Total Assets 29.79M Working Capital 3.25M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -83.55M
and capital expenditures -522K, giving a free cash flow of -84.07M.
Operating Cash Flow -83.55M Capital Expenditures -522K Free Cash Flow -84.07M FCF Per Share -2.92
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -383.68% and -372.08%.
Gross Margin 100% Operating Margin -383.68% Pretax Margin -377.88% Profit Margin -372.08% EBITDA Margin -281.91% EBIT Margin -383.68% FCF Margin -399.79%
Dividends & Yields SQZ does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield -366.97% FCF Yield -394.3%
Dividend Details Analyst Forecast Currently there are no analyst rating for SQZ.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 7, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 7, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -22.94 Piotroski F-Score 2
